文献速递糖尿病肥胖与代谢综合征

肝细胞中的Tcf7l2调控饮食诱导的非酒精性脂肪性肝病小鼠的从头脂肪生成

Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice.
PubMed 文献 · Diabetologia · 2023-02-10

本研究在C57BL/6N小鼠中通过Alb-Cre重组酶系统选择性敲除肝细胞Tcf7l2,分别给予高脂饮食或高碳水化合物饮食22周以复制NAFLD/NASH。结果显示,肝细胞Tcf7l2缺失通过激活从头脂肪生成(DNL)优先代谢碳水化合物,从而加剧肝脂肪变性;在生理水平恢复Tcf7l2表达可减轻急性及慢性高碳水化合物饮食下的肝脂肪变性,且不改变体成分。

要点

  • 肝细胞Tcf7l2缺失在高碳水化合物饮食条件下加剧肝脂肪变性,且呈碳水化合物暴露时间和剂量依赖性。
  • TCF7L2通过调控ChREBP的O-GlcNAc修饰及蛋白含量,并经miR-33-5p靶向SREBP1,调节DNL相关基因转录。
  • 在肝内恢复Tcf7l2至生理水平可减轻高碳水化合物饮食诱导的肝脂肪变性,不改变体成分。

核心结论

  • 在小鼠中,肝细胞Tcf7l2缺失通过激活DNL促进碳水化合物优先代谢,从而导致肝脂肪变性;TCF7L2可能是与高碳水化合物饮食和糖尿病相关NAFLD的有前景的调控因子。

研究设计与样本

  • 研究采用肝细胞特异性Tcf7l2敲除小鼠(Alb-Cre;Tcf7l2f/f)及其野生型同窝对照(Tcf7l2f/f),均为C57BL/6N背景,分别给予高脂饮食或高碳水化合物饮食22周以复制NAFLD/NASH。

主要发现

  • 正常饮食下,Alb-Cre;Tcf7l2f/f小鼠肝脏脂肪生成基因表达增加,但肝脏脂质含量无变化。
  • 饮食诱导NAFLD/NASH 22周后,肝细胞Tcf7l2缺失小鼠的肝脂肪变性加重,归因于碳水化合物优先于脂肪代谢。
  • 肝细胞Tcf7l2缺失以碳水化合物暴露持续时间和剂量依赖的方式增加肝脏脂质含量,由肝细胞自主性DNL增加所致。
  • 机制上,TCF7L2通过调节ChREBP的O-GlcNAc修饰及蛋白含量调控Mlxipl转录活性,并经miR-33-5p靶向Srebf1。
  • 在急性及慢性高碳水化合物饮食条件下,于Alb-Cre;Tcf7l2f/f小鼠肝脏恢复生理水平TCF7L2表达可减轻肝脂肪变性,且不改变体成分。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Non-alcoholic fatty liver disease (NAFLD) associated with type 2 diabetes may more easily progress towards severe forms of non-alcoholic steatohepatitis (NASH) and cirrhosis. Although the Wnt effector transcription factor 7-like 2 (TCF7L2) is closely associated with type 2 diabetes risk, the role of TCF7L2 in NAFLD development remains unclear. Here, we investigated how changes in TCF7L2 expression in the liver affects hepatic lipid metabolism based on the major risk factors of NAFLD development. METHODS: Tcf7l2 was selectively ablated in the liver of C57BL/6N mice by inducing the albumin (Alb) promoter to recombine Tcf7l2 alleles floxed at exon 5 (liver-specific Tcf7l2-knockout [KO] mice: Alb-Cre;Tcf7l2f/f). Alb-Cre;Tcf7l2f/f and their wild-type (Tcf7l2f/f) littermates were fed a high-fat diet (HFD) or a high-carbohydrate diet (HCD) for 22 weeks to reproduce NAFLD/NASH. Mice were refed a standard chow diet or an HCD to stimulate de novo lipogenesis (DNL) or fed an HFD to provide exogenous fatty acids. We analysed glucose and insulin sensitivity, metabolic respiration, mRNA expression profiles, hepatic triglyceride (TG), hepatic DNL, selected hepatic metabolites, selected plasma metabolites and liver histology. RESULTS: Alb-Cre;Tcf7l2f/f essentially exhibited increased lipogenic genes, but there were no changes in hepatic lipid content in mice fed a normal chow diet. However, following 22 weeks of diet-induced NAFLD/NASH conditions, liver steatosis was exacerbated owing to preferential metabolism of carbohydrate over fat. Indeed, hepatic Tcf7l2 deficiency enhanced liver lipid content in a manner that was dependent on the duration and amount of exposure to carbohydrates, owing to cell-autonomous increases in hepatic DNL. Mechanistically, TCF7L2 regulated the transcriptional activity of Mlxipl (also known as ChREBP) by modulating O-GlcNAcylation and protein content of carbohydrate response element binding protein (ChREBP), and targeted Srebf1 (also called SREBP1) via miRNA (miR)-33-5p in hepatocytes. Eventually, restoring TCF7L2 expression at the physiological level in the liver of Alb-Cre;Tcf7l2f/f mice alleviated liver steatosis without altering body composition under both acute and chronic HCD conditions. CONCLUSIONS/INTERPRETATION: In mice, loss of hepatic Tcf7l2 contributes to liver steatosis by inducing preferential metabolism of carbohydrates via DNL activation. Therefore, TCF7L2 could be a promising regulator of the NAFLD associated with high-carbohydrate diets and diabetes since TCF7L2 deficiency may lead to development of NAFLD by promoting utilisation of excess glucose pools through activating DNL. DATA AVAILABILITY: RNA-sequencing data have been deposited into the NCBI GEO under the accession number GSE162449 ( www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE162449 ).

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Lee DS, An TH, Kim H, et al. Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice. Diabetologia. 2023. PMID: 36759348. doi:10.1007/s00125-023-05878-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。